Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy
Public ClinicalTrials.gov record NCT00083486. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the effectiveness of different doses of epoetin alfa for treating anemia in patients who have cancer; or patients who no longer have any signs of cancer, but remain anemic as a result of their treatment. These patients should not be currently receiving chemotherapy or radiotherapy. A subject's participation in the study will last approximately 6 months. Subjects will receive weekly doses of epoetin alfa or placebo. Their hemoglobin will be tested every week.
Study identification
- NCT ID
- NCT00083486
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Oct 2004 (Actual)
- Last update posted
- Apr 27, 2011
2004
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Heritage Physician Group-Oncology | Hot Springs | Arkansas | 71913 | — |
| Spalding Oncology Services | Griffin | Georgia | 30224 | — |
| Southern Illinois Hematology | Centralia | Illinois | 62801 | — |
| BioLab Research | Rockville | Maryland | 20852 | — |
| Slocum-Dickson Medical Group, PC | New Hartford | New York | 13413 | — |
| NorthEast Urology Research | Concord | North Carolina | — | — |
| Mid Ohio Oncology Hematology | Columbus | Ohio | 43213 | — |
| Drexel University College of Medicine | Philadelphia | Pennsylvania | 19102 | — |
| Caroline Cancer Center | Aiken | South Carolina | 29403 | — |
| Charleston Hematology Oncology | Charleston | South Carolina | 29403 | — |
| Charleston Cancer Care | Charleston | South Carolina | 29406 | — |
| Volunteer Research Group | Knoxville | Tennessee | 37920 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00083486, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2011 · Synced Oct 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00083486 live on ClinicalTrials.gov.